Business News

Infosys stock falls 4% after mixed Q2 show: Here’s what brokerages are saying

Shares of Infosys in Friday trading fell more than 4 percent from the day’s low of Rs 1,889 per share after the company released its Q2 results with strong margins sequentially. Ahead of the results, the company’s shares ended nearly 3 percent higher at Rs 1,969.5 per share on the BSE.

Bengaluru-headquartered IT major Infosys released its September quarter results on Thursday. During the review period, the company’s revenue in constant currency (CC) grew by 3.3 percent YoY as well
3.1% QoQ. Zee Business Research estimates that revenue will grow by 3 percent.

Operating margin at the software services company has been stable sequentially (QoQ).

Net profit at the company in the September quarter grew to Rs 6,506 crore, up 2.2 percent sequentially and 4.7 percent year-on-year. Zee Business Research estimates consolidated PAT for the company to rise 5.5 percent sequentially to Rs 6,720 crore.

Are brokerages looking at Infosys stock after Q2 results?

Morgan Stanley maintained its overweight rating on the stock with a price target of Rs 2,150 per share. The target means a rise of more than 9 percent. With a slight miss on 2Q earnings and weak deal wins, the brokerage sees little correction in the stock as possible in the near term. The brokerage advises stocks to build positions in any potential correction.

The brokerage sees support at a 5-year FCF multiple of 24 times i.e. at Rs 1,780 per share.

Citi, however, maintained its neutral call on the stock with a target of Rs 1,965. According to the brokerage, the company posted a decent Q2 with cc revenue growth of 3.1 percent sequentially.

Also, the higher end of the revenue guidance is raised which is better than peers.

The forward-looking indicators for the stock as stated by Citi are:

a) Gross TCV – down 7.4% TTM yoy
b) Head count -3% yoy
c) Guidance implies no growth in 3Q/4Q in the middle

Infosys (CMP:1968)

A brokerage

Average

New Target

Old Target

Jeffries

Buy it

2220

2040

JP Morgan

Being overweight

2250

Morgan Stanley

Being overweight

2150

Nomura

Buy it

2130

CLSA

Hold on

1837

1803

Citi

Neutrality

1965

Get all the latest stock market updates here. For all other news in trending sectors like technology, automobiles and personal finance, and much more, visit Zeebiz.com.




Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button